Home
Home

Atripla

Consider Biotech Gilead Sciences Because Of Atripla, Sofosbuvir And Great R&D

Consider Biotech Gilead Sciences Because Of Atripla, Sofosbuvir And Great R&D
Seeking Alpha

Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla In Test

Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla In Test
Bloomberg

Gilead’s Experimental 4-in-1 AIDS Pill Effective as Current Drug in Study

Gilead’s Experimental 4-in-1 AIDS Pill Effective as Current Drug in Study
Bloomberg

Lofty hopes confront Gilead's 4-drug HIV pill

Lofty hopes confront Gilead's 4-drug HIV pill
Reuters

Analyst sees low physician expectations for new Gilead HIV treatment Complera

Analyst sees low physician expectations for new Gilead HIV treatment Complera
Yahoo/AP

Gilead gets subpoena from Justice Department

Gilead gets subpoena from Justice Department
MarketWatch

News

Gilead's Quad HIV Pill Better Than Best-Selling Atripla in 48-Week Study
Bloomberg
»

News

Gilead CEO Sees Sales Gains on Earlier AIDS Treatment
Bloomberg
»

News

Gilead Sciences sues Teva over generic AIDS drug
Globes, Israel
»